Create free account
ActiveThane, MaharashtraSince 2021

Genome Valley Pharma Parks and Incubators Private Limited

Follow

Set up in 2021 in Thane. It has pledged its assets against loans of up to ₹285 crore from 1 lender.

CINU24290MH2021PTC459547
Get its revenue and profit

From its annual accounts, which Entiva gets and reads for you.

Ask your favourite AI

Get a plain-English summary of this company.

5 years at a glance

Loans against its assets, and when today's people joined

20222023202420252026LOANS AGAINST ITS ASSETSTODAY'S PEOPLE, WHEN THEY JOINEDRegistered as a companyAxis Bank Limited, up to ₹285 crore, 29 Nov 2023 to still open
Loan still openLoan paid offSomeone joined, and is still there
  • 2021Registered as a company on 10 Jun 2021.
  • 2023Its biggest loan against assets, ₹285 crore with Axis Bank Limited, is still open.

Who runs it

This page does not list its directors yet. Open the company in Entiva to see who runs it on MCA's register today.

Who has lent to it

₹285 crorein loans backed by its assets, from 1 lender

  • Axis Bank Limited₹285 crore

    Open, taken out 29 Nov 2023

What its filings add

Genome Valley Pharma Parks and Incubators files these with the registrar. Entiva fetches and reads them for you.

Get Genome Valley Pharma Parks and Incubators's filings

Same line of business

Registered for the same kind of business, closest in size first

Keep an eye on Genome Valley Pharma Parks and Incubators

  • Free

    Follow the company

    An email when it files, or its directors or loans change.

  • Free

    Follow its people

    Hear when a director joins another company.

  • Free

    Map the network

    See every company its people connect to.

  • Per order

    Read the filings

    Accounts, owners and loans, in Entiva or your AI assistant.

Create a free account

No card needed to follow.

The details on this page come from public records, including MCA's register of companies as Entiva read it on . Things may have changed since. A loan amount is the most the lender can claim against the company's assets, not what is still owed.